NCT05497674View on ClinicalTrials.gov

Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 21, 2022

Primary Completion Date

July 22, 2022

Study Completion Date

February 24, 2023

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Rongliflozin

oral administration, single dose on Day 1 and Day 11

DRUG

Rifampin

QD for 10 days

DRUG

Rongliflozin

oral administration, single dose on Day 1 and Day 6

DRUG

Probenecid

twice a day, for 5 days

Trial Locations (1)

130000

The First Hospital of Jilin University, Jilin

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY